Antigen specificity and high affinity binding provided by one single loop of a camel single-domain antibody
- PMID: 11342547
- DOI: 10.1074/jbc.M102107200
Antigen specificity and high affinity binding provided by one single loop of a camel single-domain antibody
Abstract
Detailed knowledge on antibody-antigen recognition is scarce given the unlimited antibody specificities of which only few have been investigated at an atomic level. We report the crystal structures of an antibody fragment derived from a camel heavy chain antibody against carbonic anhydrase, free and in complex with antigen. Surprisingly, this single-domain antibody interacts with nanomolar affinity with the antigen through its third hypervariable loop (19 amino acids long), providing a flat interacting surface of 620 A(2). For the first time, a single-domain antibody is observed with its first hypervariable loop adopting a type-1 canonical structure. The second hypervariable loop, of unique size due to a somatic mutation, reveals a regular beta-turn. The third hypervariable loop covers the remaining hypervariable loops and the side of the domain that normally interacts with the variable domain of the light chain. Specific amino acid substitutions and reoriented side chains reshape this side of the domain and increase its hydrophilicity. Of interest is the substitution of the conserved Trp-103 by Arg because it opens new perspectives to 'humanize' a camel variable domain of heavy chain of heavy chain antibody (VHH) or to 'camelize' a human or a mouse variable domain of heavy chain of conventional antibody (VH).
Similar articles
-
A single-domain antibody fragment in complex with RNase A: non-canonical loop structures and nanomolar affinity using two CDR loops.Structure. 1999 Apr 15;7(4):361-70. doi: 10.1016/s0969-2126(99)80049-5. Structure. 1999. PMID: 10196124
-
Sequence and structure of VH domain from naturally occurring camel heavy chain immunoglobulins lacking light chains.Protein Eng. 1994 Sep;7(9):1129-35. doi: 10.1093/protein/7.9.1129. Protein Eng. 1994. PMID: 7831284
-
Single domain antibodies: comparison of camel VH and camelised human VH domains.J Immunol Methods. 1999 Dec 10;231(1-2):25-38. doi: 10.1016/s0022-1759(99)00138-6. J Immunol Methods. 1999. PMID: 10648925 Review.
-
Single domain camel antibodies: current status.J Biotechnol. 2001 Jun;74(4):277-302. doi: 10.1016/s1389-0352(01)00021-6. J Biotechnol. 2001. PMID: 11526908 Review.
-
General strategy to humanize a camelid single-domain antibody and identification of a universal humanized nanobody scaffold.J Biol Chem. 2009 Jan 30;284(5):3273-3284. doi: 10.1074/jbc.M806889200. Epub 2008 Nov 14. J Biol Chem. 2009. PMID: 19010777
Cited by
-
Modern Technologies for Creating Synthetic Antibodies for Clinical application.Acta Naturae. 2009 Apr;1(1):32-50. Acta Naturae. 2009. PMID: 22649585 Free PMC article.
-
The smart targeting of nanoparticles.Curr Pharm Des. 2013;19(35):6315-29. doi: 10.2174/13816128113199990375. Curr Pharm Des. 2013. PMID: 23470005 Free PMC article. Review.
-
A platform for post-translational spatiotemporal control of cellular proteins.Synth Biol (Oxf). 2021 Feb 2;6(1):ysab002. doi: 10.1093/synbio/ysab002. eCollection 2021. Synth Biol (Oxf). 2021. PMID: 33763602 Free PMC article.
-
Molecular dynamics simulations and docking enable to explore the biophysical factors controlling the yields of engineered nanobodies.Sci Rep. 2016 Oct 10;6:34869. doi: 10.1038/srep34869. Sci Rep. 2016. PMID: 27721441 Free PMC article.
-
Loss-of-function screening by randomized intracellular antibodies: identification of hnRNP-K as a potential target for metastasis.Proc Natl Acad Sci U S A. 2007 May 22;104(21):8983-8. doi: 10.1073/pnas.0607595104. Epub 2007 May 4. Proc Natl Acad Sci U S A. 2007. PMID: 17483488 Free PMC article.
Publication types
MeSH terms
Substances
Associated data
- Actions
- Actions
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
